Top News

Jan 24, 2017
Merck will pay a one-time fee of $625 million and additional royalties to BMS and Ono Pharmaceutical to settle the patent infringement case related to Keytruda.
Jan 19, 2017
Researchers were not able to replicate all of the findings in five highly-cited cancer biology papers.
Jan 18, 2017
A new document discusses the exclusivity period for authorized generics, but does not tackle the issue of pay-for-delay agreements.
Jan 17, 2017
FDA released a long-awaited draft guidance to help sponsors seeking to demonstrate interchangeability for biosimilar products.
Jan 11, 2017
Industry experts identify the future focus of the biopharma industry in a new survey.
Jan 05, 2017
By Pharmaceutical Technology Editors
J&J’s Innovation Global announced the company has entered into 15 new collaborations.
Jan 05, 2017
The number of novel drugs approved in 2016 by FDA’s CDER department was half the number approved the previous year; many of the complete response letters issued in 2016 were a result of preapproval inspection.
Dec 15, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Lonza adds CDMO, capsule, and consumer healthcare and nutrition capabilities with $5.5-billion acquisition of Capsugel.
Dec 01, 2016
The House-approved 21st Century Cures legislation supports initiatives for medical research, drug development, and faster approvals, but comes up short on actual appropriations.
Nov 30, 2016
By Pharmaceutical Technology Editors
Takeda will invest more than 100 million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.
lorem ipsum